// App-Quantinova.ai

9552 : Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma.

Researchers

Presenter

  • Allison Betof Warner

Principal Investigators

  • Alexander Noor Shoushtari

  • Sean Houghton

  • Katherine Panageas

  • Paul B. Chapman

  • Jedd D. Wolchok

  • Michael A. Postow

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved